Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)

NCT ID: NCT01553591

Last Updated: 2018-09-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1282 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-05-29

Study Completion Date

2014-07-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of eluxadoline (JNJ-27018966) compared with placebo in the treatment of participants with diarrhea-predominant irritable bowel syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eluxadoline 75 mg

Eluxadoline 75 mg tablets, orally, twice daily for up to 52 weeks period.

Group Type EXPERIMENTAL

Eluxadoline

Intervention Type DRUG

Oral tablets twice daily

Eluxadoline 100 mg

Eluxadoline 100 mg tablets, orally, twice daily for up to 52 weeks period.

Group Type EXPERIMENTAL

Eluxadoline

Intervention Type DRUG

Oral tablets twice daily

Placebo

Eluxadoline placebo matching tablets, orally, twice daily for up to 52 weeks period.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Oral tablets twice daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eluxadoline

Oral tablets twice daily

Intervention Type DRUG

Placebo

Oral tablets twice daily

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

JNJ-27018966

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Participant has a diagnosis of irritable bowel syndrome (IBS) with a subtype of diarrhea defined by the Rome III criteria.
2. Participant has had a colonoscopy performed:

* Within 10 years prior to Prescreening if participant is at least 50 years of age (sigmoidoscopy, double contrast barium enema, or computed tomography (CT) colonography within the past 5 years is acceptable)
* Since the onset (if applicable) of any of the following alarm features for participants of any age:

* Participant has documented weight loss within the past 6 months
* Participant has nocturnal symptoms
* Participant has a familial history of first-degree relatives with colon cancer or
* Participant has blood mixed with their stool (excluding blood from hemorrhoids).
3. Female participants must be:

* Postmenopausal, defined as 52 years or older and amenorrheic for at least 2 years at Prescreening,
* Surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy),
* Abstinent, or
* If sexually active, be practicing an effective method of birth control.

Exclusion Criteria

1. Participant has a diagnosis of IBS with a subtype of constipation, mixed IBS, or unsubtyped IBS by the Rome III criteria.
2. Participant has a history of inflammatory or immune-mediated gastrointestinal (GI) disorders including inflammatory bowel disease (ie, Crohn's disease, ulcerative colitis) and celiac disease.
3. Participant has a history of diverticulitis within 3 months prior to Prescreening.
4. Participant has a history of intestinal obstruction, stricture, toxic megacolon, GI perforation, fecal impaction, gastric banding, bariatric surgery, adhesions, ischemic colitis, or impaired intestinal circulation (eg, aortoiliac disease).
5. Participant has any of the following surgical history:

* Cholecystectomy with any history of post cholecystectomy biliary tract pain
* Any abdominal surgery within the 3 months prior to Prescreening
* Participant has a history of major gastric, hepatic, pancreatic, or intestinal surgery (appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post surgery are allowed)

Other protocol-specific eligibility criteria may apply.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Furiex Pharmaceuticals, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Furiex Research Site

Athens, Alabama, United States

Site Status

Furiex Research Site

Birmingham, Alabama, United States

Site Status

Furiex Research Site

Foley, Alabama, United States

Site Status

Furiex Research Site

Huntsville, Alabama, United States

Site Status

Furiex Research Site

Ozark, Alabama, United States

Site Status

Furiex Research Site

Chandler, Arizona, United States

Site Status

Furiex Research Site

Glendale, Arizona, United States

Site Status

Furiex Research Site

Mesa, Arizona, United States

Site Status

Furiex Research Site

Phoenix, Arizona, United States

Site Status

Furiex Research Site

Tucson, Arizona, United States

Site Status

Furiex Research Site

Little Rock, Arkansas, United States

Site Status

Furiex Research Site

Little Rock, Arkansas, United States

Site Status

Furiex Research Site

North Little Rock, Arkansas, United States

Site Status

Furiex Research Site

Azusa, California, United States

Site Status

Furiex Research Site

Bell Gardens, California, United States

Site Status

Furiex Research Site

Beverly Hills, California, United States

Site Status

Furiex Research Site

Carson, California, United States

Site Status

Furiex Research Site

Chula Vista, California, United States

Site Status

Furiex Research Site

Corona, California, United States

Site Status

Furiex Research Site

El Cajon, California, United States

Site Status

Furiex Research Site

Encino, California, United States

Site Status

Furiex Research Site

Garden Grove, California, United States

Site Status

Furiex Research Site

Lomita, California, United States

Site Status

Furiex Research Site

Los Angeles, California, United States

Site Status

Furiex Research Site

Monterey Park, California, United States

Site Status

Furiex Research Site

Murrieta, California, United States

Site Status

Furiex Research Site

Newport Beach, California, United States

Site Status

Furiex Research Site

North Hollywood, California, United States

Site Status

Furiex Research Site

Oakland, California, United States

Site Status

Furiex Research Site

Oxnard, California, United States

Site Status

Furiex Research Site

Pismo Beach, California, United States

Site Status

Furiex Research Site

Poway, California, United States

Site Status

Furiex Research Site

Riverside, California, United States

Site Status

Furiex Research Site

Roseville, California, United States

Site Status

Furiex Research Site

Sacramento, California, United States

Site Status

Furiex Research Site

San Diego, California, United States

Site Status

Furiex Research Site

San Diego, California, United States

Site Status

Furiex Research Site

Santa Monica, California, United States

Site Status

Furiex Research Site

Thousand Oaks, California, United States

Site Status

Furiex Research Site

Colorado Springs, Colorado, United States

Site Status

Furiex Research Site

Colorado Springs, Colorado, United States

Site Status

Furiex Research Site

Lafayette, Colorado, United States

Site Status

Furiex Research Site

Lakewood, Colorado, United States

Site Status

Furiex Research Site

Longmont, Colorado, United States

Site Status

Furiex Research Site

Norwalk, Connecticut, United States

Site Status

Furiex Research Site

Ridgefield, Connecticut, United States

Site Status

Furiex Research Site

Boca Raton, Florida, United States

Site Status

Furiex Research Site

Brandon, Florida, United States

Site Status

Furiex Research Site

Clearwater, Florida, United States

Site Status

Furiex Research Site

Cooper City, Florida, United States

Site Status

Furiex Research Site

Coral Springs, Florida, United States

Site Status

Furiex Research Site

Crystal River, Florida, United States

Site Status

Furiex Research Site

Doral, Florida, United States

Site Status

Furiex Research Site

Eustis, Florida, United States

Site Status

Furix Research Site

Hialeah, Florida, United States

Site Status

Furiex Research Site

Hialeah, Florida, United States

Site Status

Furiex Research Site

Inverness, Florida, United States

Site Status

Furiex Research Site

Jacksonville, Florida, United States

Site Status

Furiex Research Site

Kissimmee, Florida, United States

Site Status

Furiex Research Site

Maitland, Florida, United States

Site Status

Furiex Research Site

Melbourne, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami Springs, Florida, United States

Site Status

Furiex Research Site

Miramar, Florida, United States

Site Status

Furiex Research Site

Naples, Florida, United States

Site Status

Furiex Research Site

New Port Richey, Florida, United States

Site Status

Furiex Research Site

New Smyrna Beach, Florida, United States

Site Status

Furiex Research Site

Orlando, Florida, United States

Site Status

Furiex Research Site

Orlando, Florida, United States

Site Status

Furiex Research Site

Orlando, Florida, United States

Site Status

Furiex Research Site

Ormond Beach, Florida, United States

Site Status

Furiex Research Site

Oviedo, Florida, United States

Site Status

Furiex Research Site

Palm Beach, Florida, United States

Site Status

Furiex Research Site

Pinellas Park, Florida, United States

Site Status

Furiex Research Site

Pinellas Park, Florida, United States

Site Status

Furiex Research Site

Port Orange, Florida, United States

Site Status

Furiex Research Site

Sanford, Florida, United States

Site Status

Furiex Research Site

Sebastian, Florida, United States

Site Status

Furiex Research Site

South Miami, Florida, United States

Site Status

Furiex Research Site

Tampa, Florida, United States

Site Status

Furiex Research Site

Tampa, Florida, United States

Site Status

Furiex Research Site

Venice, Florida, United States

Site Status

Furiex Research Site

Wellington, Florida, United States

Site Status

Furiex Research Site

Winter Haven, Florida, United States

Site Status

Furiex Research Site

Winter Park, Florida, United States

Site Status

Furiex Research Site

Atlanta, Georgia, United States

Site Status

Furiex Research Site

Blue Ridge, Georgia, United States

Site Status

Furiex Research Site

Johns Creek, Georgia, United States

Site Status

Furiex Research Site

Lilburn, Georgia, United States

Site Status

Furiex Research Site

Oakwood, Georgia, United States

Site Status

Furiex Research Site

Perry, Georgia, United States

Site Status

Furiex Research Site

Snellville, Georgia, United States

Site Status

Furiex Research Site

Eagle, Idaho, United States

Site Status

Furiex Research Site

Addison, Illinois, United States

Site Status

Furiex Research Site

Chicago, Illinois, United States

Site Status

Furiex Research Site

Morton, Illinois, United States

Site Status

Furiex Research Site

Brownsburg, Indiana, United States

Site Status

Furiex Research Site

Evansville, Indiana, United States

Site Status

Furiex Research Site

Indianapolis, Indiana, United States

Site Status

Furiex Research Site

Clive, Iowa, United States

Site Status

Furiex Research Site

Davenport, Iowa, United States

Site Status

Furiex Research Site

Iowa City, Iowa, United States

Site Status

Furiex Research Site

West Des Moines, Iowa, United States

Site Status

Furiex Research Site

Newton, Kansas, United States

Site Status

Furiex Research Site

Prairie Village, Kansas, United States

Site Status

Furiex Research Site

Shawnee Mission, Kansas, United States

Site Status

Furiex Research Site

Wichita, Kansas, United States

Site Status

Furiex Research Site

Wichita, Kansas, United States

Site Status

Furiex Research Site

Crestview Hills, Kentucky, United States

Site Status

Furiex Research Site

Hawesville, Kentucky, United States

Site Status

Furiex Research Site

Lexington, Kentucky, United States

Site Status

Furiex Research Site

Lexington, Kentucky, United States

Site Status

Furiex Research Site

Louisville, Kentucky, United States

Site Status

Furiex Research Site

Madisonville, Kentucky, United States

Site Status

Furiex Research Site

Owensboro, Kentucky, United States

Site Status

Furiex Research Site

Baker, Louisiana, United States

Site Status

Furiex Research Site

Covington, Louisiana, United States

Site Status

Furiex Research Site

Hammond, Louisiana, United States

Site Status

Furiex Research Site

Metairie, Louisiana, United States

Site Status

Furiex Research Site

New Orleans, Louisiana, United States

Site Status

Furiex Research Site

Opelousas, Louisiana, United States

Site Status

Furiex Research Site

Shreveport, Louisiana, United States

Site Status

Furiex Research Site

Shreveport, Louisiana, United States

Site Status

Furiex Research Site

Bangor, Maine, United States

Site Status

Furiex Research Site

Annapolis, Maryland, United States

Site Status

Furiex Research Site

Chevy Chase, Maryland, United States

Site Status

Furiex Research Site

Brockton, Massachusetts, United States

Site Status

Furiex Research Site

Watertown, Massachusetts, United States

Site Status

Furiex Research Site

Ann Arbor, Michigan, United States

Site Status

Furiex Research Site

Southfield, Michigan, United States

Site Status

Furiex Research Site

Stevensville, Michigan, United States

Site Status

Furiex Research Site

Chaska, Minnesota, United States

Site Status

Furiex Research Site

Jackson, Mississippi, United States

Site Status

Furiex Research Site

City of Saint Peters, Missouri, United States

Site Status

Furiex Research Site

Jefferson City, Missouri, United States

Site Status

Furiex Research Site

St Louis, Missouri, United States

Site Status

Furiex Research Site

St Louis, Missouri, United States

Site Status

Furiex Research Site

Billings, Montana, United States

Site Status

Furiex Research Site

Bellevue, Nebraska, United States

Site Status

Furiex Research Site

Omaha, Nebraska, United States

Site Status

Furiex Research Site

Omaha, Nebraska, United States

Site Status

Furiex Research Site

Las Vegas, Nevada, United States

Site Status

Furiex Research Site

Las Vegas, Nevada, United States

Site Status

Furiex Research Site

Collingswood, New Jersey, United States

Site Status

Furiex Research Site

Edison, New Jersey, United States

Site Status

Furiex Research Site

Albuquerque, New Mexico, United States

Site Status

Furiex Research Site

Brooklyn, New York, United States

Site Status

Furiex Research Site

Endwell, New York, United States

Site Status

Furiex Research Site

Great Neck, New York, United States

Site Status

Furiex Research Site

Hartsdale, New York, United States

Site Status

Furiex Research Site

Kew Gardens, New York, United States

Site Status

Furiex Research Site

New Windsor, New York, United States

Site Status

Furiex Research Site

New York, New York, United States

Site Status

Furiex Research Site

North Massapequa, New York, United States

Site Status

Furiex Research Site

Poughkeepsie, New York, United States

Site Status

Furiex Research Site

Asheville, North Carolina, United States

Site Status

Furiex Research Site

Asheville, North Carolina, United States

Site Status

Furiex Research Site

Charlotte, North Carolina, United States

Site Status

Furiex Research Site

Durham, North Carolina, United States

Site Status

Furiex Research Site

Fayetteville, North Carolina, United States

Site Status

Furiex Research Site

Greensboro, North Carolina, United States

Site Status

Furiex Research Site

Hickory, North Carolina, United States

Site Status

Furiex Research Site

High Point, North Carolina, United States

Site Status

Furiex Research Site

Kinston, North Carolina, United States

Site Status

Furiex Research Site

Lenoir, North Carolina, United States

Site Status

Furiex Research Site

Raleigh, North Carolina, United States

Site Status

Furiex Research Site

Raleigh, North Carolina, United States

Site Status

Furiex Research Site

Salisbury, North Carolina, United States

Site Status

Furiex Research Site

Winston-Salem, North Carolina, United States

Site Status

Furiex Research Site

Fargo, North Dakota, United States

Site Status

Furiex Research Site

Fargo, North Dakota, United States

Site Status

Furiex Research Site

Beavercreek, Ohio, United States

Site Status

Furiex Research Site

Berea, Ohio, United States

Site Status

Furiex Research Site

Centerville, Ohio, United States

Site Status

Furiex Research Site

Cincinnati, Ohio, United States

Site Status

Furiex Research Site

Cincinnati, Ohio, United States

Site Status

Furiex Research Site

Columbus, Ohio, United States

Site Status

Furiex Research Site

Dayton, Ohio, United States

Site Status

Furiex Research Site

Dayton, Ohio, United States

Site Status

Furiex Research Site

Englewood, Ohio, United States

Site Status

Furiex Research Site

Franklin, Ohio, United States

Site Status

Furiex Research Site

Marion, Ohio, United States

Site Status

Furiex Research Site

Miamisburg, Ohio, United States

Site Status

Furiex Research Site

Middleburg Heights, Ohio, United States

Site Status

Furiex Research Site

Wadsworth, Ohio, United States

Site Status

Furiex Research Site

Zanesville, Ohio, United States

Site Status

Furiex Research Site

Tulsa, Oklahoma, United States

Site Status

Furiex Research Site

Tulsa, Oklahoma, United States

Site Status

Furiex Research Site

Tulsa, Oklahoma, United States

Site Status

Furiex Research Site

Belle Vernon, Pennsylvania, United States

Site Status

Furiex Research Site

Jenkintown, Pennsylvania, United States

Site Status

Furiex Research Site

Johnstown, Pennsylvania, United States

Site Status

Furiex Research Site

Lansdale, Pennsylvania, United States

Site Status

Furiex Research Site

Philadelphia, Pennsylvania, United States

Site Status

Furiex Research Site

Philadelphia, Pennsylvania, United States

Site Status

Furiex Research Site

Pittsburgh, Pennsylvania, United States

Site Status

Furiex Research Site

Pittsburgh, Pennsylvania, United States

Site Status

Furiex Research Site

Uniontown, Pennsylvania, United States

Site Status

Furiex Research Site

Upper Saint Clair, Pennsylvania, United States

Site Status

Furiex Research Site

Cumberland, Rhode Island, United States

Site Status

Furiex Research Site

East Providence, Rhode Island, United States

Site Status

Furiex Research Site

Anderson, South Carolina, United States

Site Status

Furiex Research Site

Charleston, South Carolina, United States

Site Status

Furiex Research Site

Fort Mill, South Carolina, United States

Site Status

Furiex Research Site

Greenville, South Carolina, United States

Site Status

Furiex Research Site

Greer, South Carolina, United States

Site Status

Furiex Research Site

Greer, South Carolina, United States

Site Status

Furiex Research Site

Myrtle Beach, South Carolina, United States

Site Status

Furiex Research Site

Myrtle Beach, South Carolina, United States

Site Status

Furiex Research Site

Simpsonville, South Carolina, United States

Site Status

Furiex Research Site

Summerville, South Carolina, United States

Site Status

Furiex Research Site

Bristol, Tennessee, United States

Site Status

Furiex Research Site

Chattanooga, Tennessee, United States

Site Status

Furiex Research Site

Clarksville, Tennessee, United States

Site Status

Furiex Research Site

Columbia, Tennessee, United States

Site Status

Furiex Research Site

Franklin, Tennessee, United States

Site Status

Furiex Research Site

Johnson City, Tennessee, United States

Site Status

Furiex Research Site

Memphis, Tennessee, United States

Site Status

Furiex Research Site

Smyrna, Tennessee, United States

Site Status

Furiex Research Site

Austin, Texas, United States

Site Status

Furiex Research Site

Austin, Texas, United States

Site Status

Furiex Research Site

Baytown, Texas, United States

Site Status

Furiex Research Site

Beaumont, Texas, United States

Site Status

Furiex Research Site

Dallas, Texas, United States

Site Status

Furiex Research Site

El Paso, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Marshall, Texas, United States

Site Status

Furiex Research Site

Plano, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

Sugar Land, Texas, United States

Site Status

Furiex Research Site

Clinton, Utah, United States

Site Status

Furiex Research Site

Draper, Utah, United States

Site Status

Furiex Research Site

Logan, Utah, United States

Site Status

Furiex Research Site

Ogden, Utah, United States

Site Status

Furiex Research Site

Salt Lake City, Utah, United States

Site Status

Furiex Research Site

West Jordan, Utah, United States

Site Status

Furiex Research Site

Lynchburg, Virginia, United States

Site Status

Furiex Research Site

Richmond, Virginia, United States

Site Status

Furiex Research Site

Williamsburg, Virginia, United States

Site Status

Furiex Research Site

Spokane, Washington, United States

Site Status

Furiex Research Site

Spokane, Washington, United States

Site Status

Furiex Research Site

Spokane, Washington, United States

Site Status

Furiex Research Site

Wenatchee, Washington, United States

Site Status

Furiex Research Site

Morgantown, West Virginia, United States

Site Status

Furiex Research Site

Wauwatosa, Wisconsin, United States

Site Status

Furiex Research Site

Kamloops, British Columbia, Canada

Site Status

Furiex Research Site

Kelowna, British Columbia, Canada

Site Status

Furiex Research Site

Winnipeg, Manitoba, Canada

Site Status

Furiex Research Site

Bridgewater, Nova Scotia, Canada

Site Status

Furiex Research Site

Halifax, Nova Scotia, Canada

Site Status

Furiex Research Site

Cambridge, Ontario, Canada

Site Status

Furiex Research Site

London, Ontario, Canada

Site Status

Furiex Research Site

Niagara Falls, Ontario, Canada

Site Status

Furiex Research Site

Oshawa, Ontario, Canada

Site Status

Furiex Research Site

Chesterfield, Derbyshire, United Kingdom

Site Status

Furiex Research Site

Blackpool, Lancashire, United Kingdom

Site Status

Furiex Research Site

Thornton-Cleveleys, Lancashire, United Kingdom

Site Status

Furiex Research Site

Burbage, Leicestershire, United Kingdom

Site Status

Furiex Research Site

Royal Leamington Spa, Warwickshire, United Kingdom

Site Status

Furiex Research Site

Chippenham, Wiltshire, United Kingdom

Site Status

Furiex Research Site

Bath, , United Kingdom

Site Status

Furiex Research Site

Bath, , United Kingdom

Site Status

Furiex Research Site

Coventry, , United Kingdom

Site Status

Furiex Research Site

Dorking, , United Kingdom

Site Status

Furiex Research Site

Haxey, , United Kingdom

Site Status

Furiex Research Site

London, , United Kingdom

Site Status

Furiex Research Site

Shrewsbury, , United Kingdom

Site Status

Furiex Research Site

Southampton, , United Kingdom

Site Status

Furiex Research Site

Strensall, , United Kingdom

Site Status

Furiex Research Site

Thornton, , United Kingdom

Site Status

Furiex Research Site

Torpoint, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1021-1029.e6. doi: 10.1016/j.cgh.2017.01.026. Epub 2017 Feb 3.

Reference Type DERIVED
PMID: 28167156 (View on PubMed)

Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS. Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med. 2016 Jan 21;374(3):242-53. doi: 10.1056/NEJMoa1505180.

Reference Type DERIVED
PMID: 26789872 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-001600-38

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

27018966IBS3001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.